ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001392459

Campanelli Paul

CIK 0001392459 Name as filed on the most recent filing

Filed as Campanelli Paul (10)

120 transaction lines · from 10 filings · filed 2007-10-03 to 2017-08-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

120 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2017-08-14 Endo International plc
ENDP 		P, Open-market purchase 6,500 acquired 7.71 50,115.00 Form 4, filing 0001209191-17-048879
2017-03-16 Endo International plc
ENDP 		P, Open-market purchase 2,300 acquired 10.72 24,656.00 Form 4, filing 0001209191-17-021162
2016-05-10 Endo International plc
ENDP 		P, Open-market purchase 13,000 acquired 15.53 201,890.00 Form 4, filing 0001209191-16-119062
2015-11-11 Endo International plc
ENDP 		P, Open-market purchase 1,900 acquired 55.62 105,678.00 Form 4, filing 0001209191-15-079481
2015-11-11 Endo International plc
ENDP 		P, Open-market purchase 200 acquired 56.38 11,276.00 Form 4, filing 0001209191-15-079481
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 1,100 disposed 30.53 33,583.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 1,000 disposed 30.54 30,540.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 550 disposed 30.50 16,775.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 500 disposed 30.56 15,280.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 500 disposed 30.52 15,260.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 200 disposed 30.43 6,086.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.47 3,047.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.45 3,045.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.42 3,042.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.41 3,041.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.39 3,039.00 Form 4, filing 0000878088-11-000032
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 24,732 disposed 30.75 760,509.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 5,097 disposed 30.76 156,783.72 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 2,500 disposed 30.74 76,850.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 2,335 disposed 30.77 71,847.95 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 1,637 disposed 30.63 50,141.31 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 1,275 disposed 30.64 39,066.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 1,100 disposed 30.73 33,803.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 975 disposed 30.58 29,815.50 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 930 disposed 30.62 28,476.60 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 800 disposed 30.70 24,560.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 723 disposed 30.79 22,261.17 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 700 disposed 30.69 21,483.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 600 disposed 30.71 18,426.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 600 disposed 30.68 18,408.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 482 disposed 30.57 14,734.84 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 434 disposed 30.78 13,358.52 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 400 disposed 30.61 12,244.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 300 disposed 30.80 9,240.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 300 disposed 30.72 9,216.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 300 disposed 30.65 9,195.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 300 disposed 30.64 9,193.50 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 300 disposed 30.59 9,177.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 200 disposed 30.74 6,149.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 200 disposed 30.66 6,132.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.81 3,081.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.67 3,067.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.60 3,060.00 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.60 3,059.50 Form 4, filing 0000878088-11-000033
2011-03-08 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 100 disposed 30.58 3,058.01 Form 4, filing 0000878088-11-000033
2011-03-07 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 75,400 disposed 30.75 2,318,550.00 Form 4, filing 0000878088-11-000031
2011-03-07 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 4,500 disposed 30.76 138,420.00 Form 4, filing 0000878088-11-000031
2011-03-07 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 3,601 disposed 30.76 110,784.76 Form 4, filing 0000878088-11-000031
2011-03-07 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 2,300 disposed 30.81 70,863.00 Form 4, filing 0000878088-11-000031
2011-03-07 PAR Pharmaceutical Companies, Inc.
PRX 		S, Open-market sale 2,300 disposed 30.77 70,771.00 Form 4, filing 0000878088-11-000031

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 114
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Campanelli Paul, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001392459

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.